Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
Interest Income Expense
|
Compugen Ltd
Interest Income Expense Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Interest Income Expense
$3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
33%
|
CAGR 10-Years
0%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Interest Income Expense
$691.9k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Interest Income Expense
-₪16.8m
|
CAGR 3-Years
-599%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-37%
|
See Also
What is Compugen Ltd's Interest Income Expense?
Interest Income Expense
3m
USD
3m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Interest Income Expense amounts to 3m USD.
What is Compugen Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
0%
0%
Over the last year, the Interest Income Expense growth was 67%. The average annual Interest Income Expense growth rates for Compugen Ltd have been 17% over the past three years , 33% over the past five years .
You don't have any saved screeners yet
